A Study of the Effects of CY6463 in Participants With Alzheimer's Disease With Vascular Pathology
Clinical trial NCT04798989 · TERMINATED
Trial details
- NCT number
- NCT04798989
- Sponsor
- Tisento Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-02
- Primary completion
- 2022-11-28
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.